Fri, March 24, 2023

Leland Gershell Maintained (XFOR) at Buy with Decreased Target to $4 on, Mar 24th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. with-decreased-target-to-4-on-mar-24th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication
Leland Gershell of Oppenheimer, Maintained "X4 Pharmaceuticals, Inc." (XFOR) at Buy with Decreased Target from $5 to $4 on, Mar 24th, 2023.

Leland has made no other calls on XFOR in the last 4 months.



There are 3 other peers that have a rating on XFOR. Out of the 3 peers that are also analyzing XFOR, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Kristen Kluska of "Cantor Fitzgerald" Maintained at Buy and Held Target at $3 on, Wednesday, March 22nd, 2023
  • Swayampakula Ramakanth of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $3 on, Wednesday, March 22nd, 2023
  • Edward Tenthoff of "Piper Sandler" Initiated at Buy and Held Target at $3 on, Monday, December 12th, 2022